Hospital Affiliation

University Hospital, Newark

INSURANCE PARTICIPATION

Insurance Participation: with Provider Number (where applicable)
The information below is subject to change and should not be relied upon until after it is verified with the insurance company. In addition, psychiatric providers should be contacted directly for information on their participation with managed care and insurance companies.

Aetna, Inc.

AmeriGroup

AmeriHealth of NJ

America's Choice Provider Network (ACPN)

CHN Solutions

Clover Health Plans

Devon Health Services/ULLICO

Horizon BCBS Managed Care

Horizon NJ Health

Horizon NJ Total Care(HNJH)

Horizon PPO Network

Medicaid

Medicare

MultiPlan

Prime Health Services, Inc.

Qual Care HMO

Qual Care PPO

Three Rivers Provider Network

UHC Comm/Oxford

United Healthcare Community Plan (formerly AmeriChoice of NJ, Inc.)

WellCare Health Plans

Overview

Dr. Misha Movahed-Ezazi attended medical school at the American University of the Caribbean in Sint Maarten. She completed her residency training in Anatomical and Clinical Pathology at Hartford Hospital in Connecticut. Following her residency, she completed a 2-year Neuropathology fellowship training program at NYU Langone in Manhattan, where she was extensively trained in diagnosis of tumor and non-tumor disease of the brain and spine, autopsy pathology, molecular pathology, and telepathology/artificial intelligence. Her primary areas of research and expertise is with artificial intelligence and stimulated Raman histology (SRH) in which she conducted a the first pathology based published clinical validation study for SRH-image based intraoperative diagnosis of brain tumors alongside Dr. Daniel Orringer and Dr. Matija Snuderl, whom are experts in the field.

Education

MD, 2017, American University of the Caribbean

Licensure & Certification

Medical Licensure
New Jersey

Relevant Publications

(Textbook authorship) Diagnostic Pathology: Intraoperative Consultation, 3rd Edition

Movahed-Ezazi M, Nasir-Moin M, Fang C, Pizzillo I, Galbraith K, Drexler S, Krasnozhen-Ratush OA, Shroff S, Zagzag D, William C, Orringer D, Snuderl M. Clinical Validation of Stimulated Raman Histology for Rapid Intraoperative Diagnosis of Central Nervous System Tumors. Mod Pathol. 2023 May 17;36(9):100219. doi: 10.1016/j.modpat.2023.100219. Epub ahead of print. PMID: 37201685.

Alber, Daniel Alexander; Lee Sangwon, Karl; Smith, Andrew; Lock, Emily Katherine; Movah-Ezazi; Todd Charles Hollon, Misha MD; Oermann, Eric Karl MD; Orringer, Daniel A. MD. 506'Deep Learning-Based Image-to-Image Translation to Identify Macrophage Infiltration in High-Grade Glioma Using Label-Free Stimulated Raman Histology. Neurosurgery 70(Supplement_1):p 155, April 2024.

Lock, Emily Katherine; Alber, Daniel Alexander; Smith, Andrew; Lee Sangwon, Karl; Movah-Ezazi, Misha; Hollon, Todd Charles MD; Oermann, Eric Karl MD; Orringer, Daniel A. MD. 293'The Impact of Tumor Mutational Status on Protoporphyrin IX Accumulation in Tumor-Associated Macrophages in Glioblastoma Patients. Neurosurgery 70(Supplement_1):p 84, April 2024.

Galbraith K, Vasudevaraja V, Serrano J, Shen G, Tran I, Abdallat N, Wen M, Patel S, Movahed-Ezazi M, et al. Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing. Neurooncol Adv. 2023 Jun 26;5(1):vdad076. doi: 10.1093/noajnl/vdad076. PMID: 37476329; PMCID: PMC10355794.

Movahed-Ezazi M, Skalina KA, Parashar K, Manjila S, Vdovenko A, Iannuzzi C, Cartun RW. A Rare Presentation of Low-Grade Prostate Adenocarcinoma as Delayed Pineal Region Metastasis: A Case Report and Review of Multicenter Clinical Experience in Prostate Carcinoma Brain Metastases. J Neuropathol Exp Neurol. 2021 Aug 13. PMID: 34388234.